Cyclophosphamide Pulse Therapy in Severe Refractory Crohn's Disease: A Retrospective Multicenter Case Series

about

Cyclophosphamide Pulse Therapy in Severe Refractory Crohn's Disease: A Retrospective Multicenter Case Series

Item

http://www.wikidata.org/entity/Q56968600

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в березні 2018

@uk

name

Cyclophosphamide Pulse Therapy ...... ective Multicenter Case Series

@en

Cyclophosphamide Pulse Therapy ...... ective Multicenter Case Series

@nl

type

Item

label

Cyclophosphamide Pulse Therapy ...... ective Multicenter Case Series

@en

Cyclophosphamide Pulse Therapy ...... ective Multicenter Case Series

@nl

prefLabel

Cyclophosphamide Pulse Therapy ...... ective Multicenter Case Series

@en

Cyclophosphamide Pulse Therapy ...... ective Multicenter Case Series

@nl

P1476

Cyclophosphamide Pulse Therapy ...... ective Multicenter Case Series

@en

P2093

Andreas Stallmach

http://www.w3.org/2001/XMLSchema#string

Christian Maaser

http://www.w3.org/2001/XMLSchema#string

Florian Bär

http://www.w3.org/2001/XMLSchema#string

Jochen Maul

http://www.w3.org/2001/XMLSchema#string

Jürgen Büning

http://www.w3.org/2001/XMLSchema#string

Klaus Fellermann

http://www.w3.org/2001/XMLSchema#string

Niels Teich

http://www.w3.org/2001/XMLSchema#string

Thomas Krause

http://www.w3.org/2001/XMLSchema#string

Ulf Helwig

http://www.w3.org/2001/XMLSchema#string

P2860

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials.

Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients.

Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel disease.

Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: overview of randomized clinical studies.

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis

Clinical prognostic factors for disabling Crohn's disease: a systematic review and meta-analysis.

Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed.

Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial.

[Clinical characteristics and risk factors of refractory Crohn's disease].

P304

139-146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000481820

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30018965

http://www.w3.org/2001/XMLSchema#string

P932

5988113

http://www.w3.org/2001/XMLSchema#string